Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2015 / Article

Corrigendum | Open Access

Volume 2015 |Article ID 603232 | 1 page | https://doi.org/10.1155/2015/603232

Corrigendum to “Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro

Received01 Jun 2015
Accepted08 Jul 2015
Published19 Aug 2015

In the paper titled “Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro” [1], the words “Ran Pang and Jun-Yan Tao contribute equally to this work” should be added to the footnote. Dr. Ji-Hua Dong should be included in the author’s list, because he has contributed to the scientific content of the paper. Thus, the affiliation “Central Lab, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China” will be added as a new address as above.

References

  1. R. Pang, J.-Y. Tao, S.-L. Zhang et al., “Ethanol extract from ampelopsis sinica root exerts anti-hepatitis B virus activity via inhibition of p53 pathway in vitro,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 939205, 7 pages, 2011. View at: Publisher Site | Google Scholar

Copyright © 2015 Ran Pang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

494 Views | 227 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.